Clinical Trial Update: A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease. [Phase 1]

View source ↗

Summary

Notes the completion of a Phase 1 single-dose study of KHK6640 in Japanese patients with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• KHK6640

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED